Thymosin beta-4 + prothymosin alpha
Thymosin beta-4 + prothymosin alpha has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, May 2, 2023: “Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice”.
1 paper studies it2 findingsUpdated
See all 1 papers on thymosin beta-4 + prothymosin alpha
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Nederlandse Hartstichting and 2 more
- Animals1
What did studies of thymosin beta-4 + prothymosin alpha find?
2Studies of thymosin beta-4 + prothymosin alpha measured 2 outcomes; the most studied are cardiac dysfunction (1 study) and cardiomyocyte proliferation (1).
Cardiac dysfunction
downin mice1
1 study
Cardiac dysfunction
downin mice1
Thymosin beta-4 + prothymosin alpha decreases cardiac dysfunction in mice after ischaemic injury.
“combination of thymosin beta 4 (TMSB4) and prothymosin alpha (PTMA) provide a permissive environment for cardiomyocyte proliferation and thereby attenuated cardiac dysfunction.”
Animalsafter ischaemic injurymyocardium
Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice
Cardiovascular research
Cardiomyocyte proliferation
upin mice1
1 study
Cardiomyocyte proliferation
upin mice1
Thymosin beta-4 + prothymosin alpha increases cardiomyocyte proliferation in mice after ischaemic injury.
“thymosin beta 4 (TMSB4) and prothymosin alpha (PTMA) provide a permissive environment for cardiomyocyte proliferation”
Animalsafter ischaemic injurymyocardium
Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice
Cardiovascular research